N° 042 · Spring · 2026 Paris · Lyon · Marseille Volume I

A blueprint for the smile you have already imagined.

The Smile Blueprint is an editorial-grade investigation into the dental industry — the materials, the labs, the quotes, the lab provenance nobody else publishes. Founded by Anis, an architect by training, reviewed line-by-line.

§ 01 / What we do

Three signals.
One standard.

Every piece we publish carries one of three stamps — verified material, certified plan, or red-flag warning. Eyes on the industry, in plain language.

01 · Investigations

Field reports from labs, clinics, and the quotes that don't add up.

Long-form video and text investigations. One a week. Every claim is sourced and every material is traced back to its kiln.

Read the latest
02 · Plan reviews

Send us a treatment plan. We will read it like an architect reads a drawing.

Materials, lab provenance, line-item pricing, second-opinion math. A working review delivered as a PDF blueprint within seven days.

See a sample plan
03 · The Blueprint letter

One letter a week. Investigations, plus a working review of one reader's plan.

Free. No advertising. No sponsorship from clinics, labs, or material suppliers — ever. The only thing we sell is the review itself.

Subscribe in the footer
§ 03 / A sample blueprint

What a reviewed
plan looks like.

Every plan we review is returned as a single document — materials, provenance, line-item costs, a final stamp. The version below is the Restorative blueprint for one subscriber, redacted for publication.

theSMILEBLUEPRINT Plan · TSB-2026-0418

Restorative blueprint for A. Renaud

All-in € 9,420
01
Upper anterior · 6 veneers
Lithium disilicate · IPS e.max® · Ivoclar Vivadent
6 × unit
02
Bite calibration · digital scan
3Shape TRIOS 5 · two-pass · archived
2 × visit
03
Lab provenance · chain of custody
Verified lab · Lyon, FR · LOT 04 / 26
Verified
S Blueprint Certified · 2026 · 04 Page 01 / 04
§ 04 / By the numbers

A magazine that
also does the math.

Twelve months of publication. Plans reviewed for subscribers in fourteen countries. Zero advertising relationships with clinics, labs, or material suppliers.

042
Investigations published
1,284
Plans reviewed
14
Countries served
0
Sponsorship revenue